A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease

NCT05403827 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

644

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: K-161
DRUG: Placebo

Sponsor

Kowa Research Institute, Inc.